Aspire-Lakewood Holdings, Inc. (ASBP) stock
ASBPNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ASBPW
$7.89−0.41 (-4.94%)
Close on Nov 18, 2026Market cap $11.07MP/E –Yield –
Aspire-Lakewood net income
Net income is the profit left for shareholders after every expense, interest and tax.
Aspire-Lakewood's net income for the twelve months ending Jun 30, 2026 was -$11.05M. For fiscal 2025 it was -$24.48M.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$24.48M | – |
| FY2024 | Dec 31, 2024 | -$1.31M | -129.3% |
| FY2023 | Dec 31, 2023 | $4.46M | +33.6% |
| FY2022 | Dec 31, 2022 | $3.34M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.27M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.22M | – |
| Q4 FY2025 | Dec 31, 2025 | -$4.71M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.85M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.98M | – |
| Q1 FY2025 | Mar 31, 2025 | -$15.94M | – |
| Q4 FY2024 | Dec 31, 2024 | -$765.71K | – |
| Q3 FY2024 | Sep 30, 2024 | -$216.27K | – |
| Q2 FY2024 | Jun 30, 2024 | -$96.92K | -105.3% |
| Q1 FY2024 | Mar 31, 2024 | -$230.97K | -108.0% |
| Q4 FY2023 | Dec 31, 2023 | -$150.91K | -106.8% |
| Q3 FY2023 | Sep 30, 2023 | -$69.26K | -106.4% |
| Q2 FY2023 | Jun 30, 2023 | $1.81M | +1401.2% |
| Q1 FY2023 | Mar 31, 2023 | $2.87M | – |
| Q4 FY2022 | Dec 31, 2022 | $2.23M | – |
| Q3 FY2022 | Sep 30, 2022 | $1.08M | – |
| Q2 FY2022 | Jun 30, 2022 | $120.69K | – |
| Q1 FY2022 | Mar 31, 2022 | -$87.83K | – |
| Q3 FY2021 | Sep 30, 2021 | -$15.31K | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.38K | – |
See a number that looks wrong?